-
-
-
-
-
-
-
Raymond James Reiterates Market Perform Rating on Galapagos NV (GLPG)
-
-
-
-
-
-
-
First key steps in pipeline rebuild and strong commercial progress in H1 2022
-
-
-
-
-
-
-
Galapagos refocuses pipeline and rightsizes operations
-
-
-
-
-
-
-
Gilead Sciences (GILD), Galapagos NV (GLPG) Amend Development Agreement for Jyselec
-
-
-
-
-
-
-
Ryvu Therapeutics Reports First Quarter 2020 Financial Results
-
-
-
-
-
-
-
Strong clinical progress in H1 and transformative collaboration with Gilead announced
-
-
-
-
-
-
-
Galapagos reports on historic first quarter 2019
-
1,199,631 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

